Semi-transparent human torso rendered in blue with the heart highlighted in red and orange

Heart Failure

Last updated: 3rd Sep 2024

Heart failure arises when the heart’s ability to pump blood around the body is impaired. This deprives the body’s tissues of the oxygen and nutrients upon which their survival depends. It commonly occurs as a result of conditions such as ischaemic heart disease, diabetes and high blood pressure.

Heart failure may be classified as being either acute or chronic. Acute heart failure is characterised by a sudden onset of symptoms, whereas in chronic heart failure typically develops and worsens over time.

Examples of the symptoms associated with heart failure include dyspnoea, fatigue, difficulty exercising, and oedema, particularly peripheral oedema. Symptoms may vary depending on which side or sides of the heart are affected.

Related news and insights

Blue test tubes arranged in a line, disappearing into the background

Drug news

Cytokinetics, Incorporated announced new data at AHA meeting from post-hoc analyses of GALACTIC-HF phase III trial of omecamtiv mecarbil for cardiovascular outcomes.

Cytokinetics, Incorporated announced new data from post-hoc analyses of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase III cardiovascular outcomes clinical trial of omecamtiv mecarbil were presented at the American Heart Association Scientific Sessions 2024 in Chicago, IL.

2 mins

Drug news

TEAM-HF trial to measure pulmonary pressures using CardioMEMS HF System

Abbott announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options

3 min

Drug news

CHMP positive for Wegovy (semaglutide 2.4 mg) label in the European Union (EU)

Novo Nordisk announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy (semaglutide 2.4 mg) label in the European Union (EU)

2 min

See all news

Related Guidelines

Guideline

Cardiac arrhythmias in coronary heart disease

This guideline provides evidence-based recommendations for the management of cardiac arrest and the arrhythmias associated with ACS, chronic CHD and cardiac surgery. It excludes arrhythmias not associated with CHD such as...

1 mins

Guideline

Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses".

An update of the 2012 systematic review and meta-analyses were performed and a modified-GRADE approach was used to update the recommendation for the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnea syndrome (CSAS)...

1 min

Guideline

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

The new Guidelines have been adapted to facilitate their use in clinical practice and to meet readers’ demands by focusing on condensed, clearly presented recommendations.

1 min

See all guidelines

Related Journal Articles

Heart Failure

Related news and insights

Related Guidelines

Related Journal Articles

Related Clinical Trials